Efficacy and Safety of D-dimer, Weight, and Renal Function-Adjusted Thromboprophylaxis in Patients with Coronavirus Disease 2019 (COVID-19)

Semin Thromb Hemost. 2021 Jun;47(4):436-441. doi: 10.1055/s-0040-1722309. Epub 2021 Jan 22.
No abstract available

Publication types

  • Observational Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use*
  • Body Weight
  • C-Reactive Protein / analysis
  • COVID-19 / blood*
  • COVID-19 / complications
  • Dose-Response Relationship, Drug
  • Enoxaparin / administration & dosage
  • Enoxaparin / therapeutic use*
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis*
  • Guideline Adherence
  • Humans
  • Incidence
  • Intensive Care Units / statistics & numerical data
  • Kidney / physiopathology*
  • Male
  • Mean Platelet Volume
  • Middle Aged
  • Oxygen / blood
  • Practice Guidelines as Topic
  • Proportional Hazards Models
  • Retrospective Studies
  • Risk Factors
  • SARS-CoV-2*
  • Thrombophilia / drug therapy*
  • Thrombophilia / etiology
  • Thrombosis / epidemiology
  • Thrombosis / etiology
  • Thrombosis / prevention & control*

Substances

  • Anticoagulants
  • Enoxaparin
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • C-Reactive Protein
  • Oxygen